<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01101802</url>
  </required_header>
  <id_info>
    <org_study_id>WX18694</org_study_id>
    <secondary_id>ISRCTN</secondary_id>
    <nct_id>NCT01101802</nct_id>
  </id_info>
  <brief_title>Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE)</brief_title>
  <acronym>MISSILE</acronym>
  <official_title>A Prospective, Randomised, Double-blind, Placebo-controlled Trial Evaluating the Effects of Mycophenolate Mofetil on 'Surrogate Markers' for Atherosclerosis in Female Patients With SLE.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute of Child Health, University College London, London, UK.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Guy's and St Thomas' NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Systemic lupus erythematosus (SLE) is an independent risk factor for atherosclerosis.
      Endothelial dysfunction is the earliest marker of atherosclerosis and is measured by flow
      mediated dilation (FMD) of the brachial artery. The purpose of the study was to measure FMD
      in mild, stable SLE patients and look for change in FMD with the immunosuppressant drug
      mycophenolate mofetil (MMF).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Flow mediated dilation</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measure of endothelial function using doppler ultrasound to measure brachial artery dilation in response to increase blood flow.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BILAG, SLEDAI,</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measurements of disease activity in SLE</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">71</enrollment>
  <condition>Systemic Lupus Erythematosus</condition>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Mycophenolate mofetil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients were given 1gm bd mycophenolate mofetil for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sugar pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mycophenolate mofetil</intervention_name>
    <description>Arm 1 patients were given 1 gm bd mycophenolate mofetil for 8 weeks, The mycophenolate was dispensed as 500mg tablets.</description>
    <arm_group_label>Mycophenolate mofetil</arm_group_label>
    <other_name>Cellcept</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sugar pill</intervention_name>
    <description>Arm 2 patients were given 2 sugar pills bd for 8 weeks</description>
    <arm_group_label>Sugar pill</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female SLE patients

          -  Age 18-60 years

          -  If premenopausal using a reliable method of contraception

          -  Clinically stable disease

          -  Taking hydroxychloroquine and up to 15mgs of prednisolone daily

        Exclusion Criteria:

          -  Smokers

          -  Pregnancy or breast feeding

          -  Use of other immunosuppressants (hydroxychloroquine and stable dose of prednisolone up
             to 15 mgs daily will be permitted)

          -  Use of any investigational drug within 1 month prior to screening

          -  Acute infections 2 weeks prior to Visit 1

          -  History of ischaemic heart disease or end stage renal disease

          -  Current signs or symptoms of severe, progressive or uncontrolled hepatic,
             haematological, gastroenterological, endocrine, pulmonary, cardiac or neurological
             disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David P D'Cruz, MD, FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guys and St Thomas' NHS Foundation Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lupus Research Unit, St Thomas' Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2010</study_first_submitted>
  <study_first_submitted_qc>April 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2010</study_first_posted>
  <last_update_submitted>September 27, 2011</last_update_submitted>
  <last_update_submitted_qc>September 27, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr David D'Cruz</name_title>
    <organization>Lupus Research Unit, St Thomas' hospital</organization>
  </responsible_party>
  <keyword>SLE</keyword>
  <keyword>Atherosclerosis</keyword>
  <keyword>Endothelial function</keyword>
  <keyword>Mycophenolate mofetil</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mycophenolic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

